These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 11691541

  • 41. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease.
    Maier W, Cosentino F, Lütolf RB, Fleisch M, Seiler C, Hess OM, Meier B, Lüscher TF.
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):173-8. PubMed ID: 10672847
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
    Leung FP, Yung LM, Leung HS, Au CL, Yao X, Vanhoutte PM, Laher I, Huang Y.
    Br J Pharmacol; 2007 Sep; 152(2):223-9. PubMed ID: 17618301
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Augmented vasodilator response to L-arginine after coronary angioplasty may attenuate restenosis.
    Fukumoto Y, Urabe Y, Kubo T, Kaku T, Egashira K, Shimokawa H, Takeshita A.
    Heart Vessels; 2002 Jul; 16(5):171-4. PubMed ID: 12181589
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Local delivery of sirolimus nanoparticles for the treatment of in-stent restenosis.
    Zago AC, Raudales JC, Attizzani G, Matte BS, Yamamoto GI, Balvedi JA, Nascimento L, Kosachenco BG, Centeno PR, Zago AJ.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):E124-9. PubMed ID: 22566402
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia EJ, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R.
    J Am Coll Cardiol; 1996 Nov 15; 28(6):1437-43. PubMed ID: 8917255
    [Abstract] [Full Text] [Related]

  • 56. Guide wire-induced coronary artery spasm during percutaneous transluminal coronary angioplasty. A case report.
    Takahashi M, Ikeda U, Sekiguchi H, Fujikawa H, Shimada K, Ri T.
    Angiology; 1996 Mar 15; 47(3):305-9. PubMed ID: 8638877
    [Abstract] [Full Text] [Related]

  • 57. Morphological and functional changes in coronary vessel evoked by repeated endothelial injury in pigs.
    Saitoh S, Saito T, Ohwada T, Ohtake A, Onogi F, Aikawa K, Maehara K, Maruyama Y.
    Cardiovasc Res; 1998 Jun 15; 38(3):772-81. PubMed ID: 9747446
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Coronary vasomotion after percutaneous transluminal coronary angioplasty depends on the severity of the culprit lesion.
    Mandinov L, Kaufmann P, Staub D, Buckingham TA, Amann FW, Hess OM.
    J Am Coll Cardiol; 1997 Sep 15; 30(3):682-8. PubMed ID: 9283526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.